Deregulation of sphingolipid metabolism in Alzheimer's disease
Top Cited Papers
- 10 June 2008
- journal article
- Published by Elsevier
- Vol. 31 (3) , 398-408
- https://doi.org/10.1016/j.neurobiolaging.2008.05.010
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Involvement of astroglial ceramide in palmitic acid‐induced Alzheimer‐like changes in primary neuronsEuropean Journal of Neuroscience, 2007
- Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytesJournal of Neurochemistry, 2006
- A TrkA-to-p75NTR molecular switch activates amyloid β-peptide generation during agingBiochemical Journal, 2005
- Amyloid‐β peptide enhances tumor necrosis factor‐α‐induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytesJournal of Neurochemistry, 2005
- Modulation of Amyloid Precursor Protein Cleavage by Cellular SphingolipidsJournal of Biological Chemistry, 2004
- Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathwayThe Journal of cell biology, 2004
- Ceramide Stabilizes β-Site Amyloid Precursor Protein-cleaving Enzyme 1 and Promotes Amyloid β-Peptide BiogenesisJournal of Biological Chemistry, 2003
- Alzheimer's disease: β‐Amyloid protein and tauJournal of Neuroscience Research, 2002
- Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pHJournal of Biological Chemistry, 1998
- Membrane Components Separate Early-Onset Alzheimer’s Disease From Senile Dementia of the Alzheimer TypeInternational Psychogeriatrics, 1996